SteadyMed Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent
Mar 31, 2017 18:19 pm UTC| Business
U.S. Patent Trial and Appeal Board Cancels all claims in United Therapeutics’ ‘393 patent for purification of prostacyclin derivatives, rendering patent invalid. SteadyMed plans to file New Drug Application (NDA) for...
Towerstream Reports Upon 2016 Financial Results and Vision for 2017
Mar 31, 2017 18:15 pm UTC| Business
MIDDLETOWN, R.I., March 31, 2017 -- Towerstream Corporation (OTCQB:TWER), a Fixed Wireless Fiber Alternative Provider, announced today financial results for the year ended December 31, 2016. "Towerstream's years ending...
Mar 31, 2017 18:06 pm UTC| Business
NEW YORK, March 31, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Babcock Wilcox Enterprises, Inc. (NYSE:BW) who purchased shares between July 1, 2015...
Mar 31, 2017 18:04 pm UTC| Business
NEW YORK, March 31, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Caterpillar, Inc. (NYSE:CAT) who purchased shares between February 19, 2013 and March 1,...
Mar 31, 2017 18:01 pm UTC| Business
NEW YORK, March 31, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of SCYNEXIS, Inc. (NASDAQ:SCYX) who purchased shares (1) pursuant and/or traceable to the...
HalioDx: New data on Halioseek(TM) PD-L1/CD8 presented at AACR 2017
Mar 31, 2017 17:10 pm UTC| Business
New data on Halioseek(TM) PD-L1/CD8 presented at AACR 2017 HalioDx has developed an assay based on the dual staining of PD-L1 + and CD8+ cells enabled by advanced image analysis tool The assay shows excellent...
Mar 31, 2017 16:46 pm UTC| Business
IRVINE, Calif., March 31, 2017 -- Khang Khang LLP (the “Firm”) announces a class action lawsuit against Regulus Therapeutics, Inc. (“Regulus” or the “Company”) (Nasdaq:RGLS). Investors who purchased or otherwise...
US–India Trade Talks Race Toward USD 500 Billion Goal